Pure Global

Myoglobin Quantitative Testing Drug - Vietnam Registration 2300926ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Myoglobin Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2300926ĐKLH/BYT-HTTB and manufactured by Roche Diagnostics GmbH.

This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including DiaSys Diagnostic Systems GmbH, Roche Diagnostics (Suzhou) Ltd., and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2 Competitors
2 Recent Registrations
2300926ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2300926ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Myoglobin Quantitative Testing Drug
VN: Thuốc thử xét nghiệm định lượng myoglobin
Risk Class TTBYT Loại C

Registration Details

2300926ĐKLH/BYT-HTTB

000.00.04.G18-201011-0001

MYO2

08252629190

Company Information

GERMANY

Technical Details

In vitro testing used to quantify myoglobin in human serum and plasma on the Roche/Hitachicobasc systems.

Dates and Status

Sep 26, 2023

Companies Making Similar Products
Companies providing products similar to "Myoglobin Quantitative Testing Drug"